Genscript Biotech Corporation (1548.HK)

HKD 11.18

(2.38%)

Operating Expenses Summary of Genscript Biotech Corporation

Genscript Biotech Corporation's latest annual operating expenses in 2023 was 409.55 Million USD , up 9.91% from previous year.
Genscript Biotech Corporation's latest quarterly operating expenses in 2024 Q2 was 457.75 Million USD , up 7.02% from previous quarter.
Genscript Biotech Corporation reported a annual operating expenses of 735.72 Million USD in annual operating expenses 2022, down -8.5% from previous year.
Genscript Biotech Corporation reported a annual operating expenses of 804.05 Million USD in annual operating expenses 2021, up 47.7% from previous year.
Genscript Biotech Corporation reported a quarterly operating expenses of 433.15 Million USD for 2023 Q2, up 28.77% from previous quarter.
Genscript Biotech Corporation reported a quarterly operating expenses of 427.72 Million USD for 2023 Q4, down -1.25% from previous quarter.

Annual Operating Expenses Chart of Genscript Biotech Corporation (2023 - 2013)

Historical Annual Operating Expenses of Genscript Biotech Corporation (2023 - 2013)

Year	Operating Expenses	Operating Expenses Growth
2023	409.55 Million USD	9.91%
2022	735.72 Million USD	-8.5%
2021	804.05 Million USD	47.7%
2020	544.38 Million USD	80.53%
2019	301.54 Million USD	106.84%
2018	145.79 Million USD	117.41%
2017	67.05 Million USD	52.45%
2016	43.98 Million USD	28.05%
2015	34.35 Million USD	-4.96%
2014	36.14 Million USD	18.75%
2013	30.43 Million USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	457.75 Million USD	7.02%
2023 Q2	433.15 Million USD	28.77%
2023 Q4	427.72 Million USD	-1.25%
2023 FY	808.62 Million USD	9.91%
2022 FY	735.72 Million USD	-8.5%
2022 Q4	336.38 Million USD	-15.77%
2022 Q2	399.34 Million USD	-22.66%
2021 FY	804.05 Million USD	47.7%
2021 Q4	516.35 Million USD	79.48%
2021 Q2	287.7 Million USD	3.36%
2020 Q2	266.02 Million USD	46.95%
2020 FY	544.38 Million USD	80.53%
2020 Q4	278.35 Million USD	4.64%
2019 FY	301.54 Million USD	106.84%
2019 Q4	181.02 Million USD	50.2%
2019 Q2	120.52 Million USD	49.01%
2018 Q4	80.88 Million USD	24.62%
2018 Q2	64.9 Million USD	54.85%
2018 FY	145.79 Million USD	117.41%
2017 Q4	41.91 Million USD	66.71%
2017 FY	67.05 Million USD	52.45%
2017 Q2	25.14 Million USD	4.23%
2016 Q2	19.86 Million USD	30.89%
2016 Q4	24.12 Million USD	21.45%
2016 FY	43.98 Million USD	28.05%
2015 Q4	15.17 Million USD	-20.86%
2015 Q2	19.17 Million USD	-4.08%
2015 FY	34.35 Million USD	-4.96%
2014 Q4	19.99 Million USD	23.76%
2014 Q2	16.15 Million USD	19187.16%
2014 FY	36.14 Million USD	18.75%
2013 Q4	83.75 Thousand USD	0.0%
2013 FY	30.43 Million USD	0.0%

Peer Operating Expenses Comparison of Genscript Biotech Corporation

Name	Operating Expenses	Operating Expenses Difference
Uni-Bio Science Group Limited	325.05 Million HKD	-25.997%
CK Life Sciences Int'l., (Holdings) Inc.	739.25 Million HKD	44.599%